Calcium Acetate
14 NDCs across 10 manufacturers|14 Generic,0 Brand
Calcium Acetate is used to treat hypocalcemia, chronic kidney failure and postmenopausal osteoporosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 10, 1990, and the first generic was approved Jan 30, 2008. FDA's Orange Book lists 9 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $28 million on Calcium Acetate across 385,000 claims for 107,000 beneficiaries.
Calcium Acetate is available as 14 NDCs from 10 manufacturers (14 generic, 0 brand), with NADAC prices from $0.17 to $0.44 per EA — the most expensive product costs about 2.6× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
14
14G / 0B
Manufacturers
10
competing in market
Price Spread
$0.17 – $0.44
per EA
7d Activity
avg +1.7% WoW · of 14 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Chartwell RX LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Blood Coagulation Factor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
10 manufacturers producing CALCIUM ACETATE(2 pricing outliers)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CALCIUM ACETATE 667 MG TABLET | $0.4387 per EA | — |
CALCIUM ACETATE 667 MG TABLET | $0.4387 per EA | — |
CALCIUM ACETATE 667 MG CAPSULE | $0.1697 per EA | +1.68% |
CALCIUM ACETATE 667 MG CAPSULE | $0.1697 per EA | +1.68% |
CALCIUM ACETATE 667 MG CAPSULE | $0.1697 per EA | +1.68% |
CALCIUM ACETATE 667 MG CAPSULE | $0.1697 per EA | +1.68% |
CALCIUM ACETATE 667 MG CAPSULE | $0.1697 per EA | +1.68% |
CALCIUM ACETATE 667 MG CAPSULE | $0.1697 per EA | +1.68% |
CALCIUM ACETATE 667 MG CAPSULE | $0.1697 per EA | +1.68% |
CALCIUM ACETATE 667 MG CAPSULE | $0.1697 per EA | +1.68% |
CALCIUM ACETATE 667 MG CAPSULE | $0.1697 per EA | +1.68% |
CALCIUM ACETATE 667 MG CAPSULE | $0.1697 per EA | +1.68% |
CALCIUM ACETATE 667 MG CAPSULE | $0.1697 per EA | +1.68% |
CALCIUM ACETATE 667 MG CAPSULE | $0.1697 per EA | +1.68% |
Frequently Asked Questions
What is Calcium Acetate used to treat?
Calcium Acetate is used to treat hypocalcemia, chronic kidney failure and postmenopausal osteoporosis, per the National Library of Medicine's MED-RT classification.
When did Calcium Acetate become available as a generic?
FDA approved the first generic Calcium Acetate (ANDA) on Jan 30, 2008. The Orange Book currently lists 9 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Calcium Acetate?
In 2024, Medicare Part D spent $28 million on Calcium Acetate across 385,000 claims for 107,000 beneficiaries.
How many Calcium Acetate products are on the market?
The Calcium Acetate drug market contains 14 NDCs from 10 manufacturers — 14 generic and 0 brand products.
What is the price range for Calcium Acetate?
NADAC reference prices for Calcium Acetate range from $0.1697 to $0.4387 per EA — the most expensive product costs about 2.6× the cheapest.
Which manufacturers make Calcium Acetate?
10 manufacturers list Calcium Acetate in NADAC. Ranked by number of NDCs, the largest are Chartwell RX LLC (2), Heritage Pharmaceuticals Inc. (2), Major Pharmaceuticals (2), Hikma Pharmaceuticals USA Inc. (2), Rising Pharma Holdings Inc. (1).
How has the price of Calcium Acetate changed recently?
Over the past 7 days, 22 Calcium Acetate NDCs rose and 0 fell, with a market-wide average change of +1.7%.